Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer

NCT01234311 is registered in ClinicalTrials.gov with Active Biotech AB as lead sponsor.

NCT NCT01234311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01234311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Lead sponsor
Active Biotech AB
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2011
Completion date
August 31, 2015
Enrollment
1,245 (actual)
Sites
204

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer